Eos Energy stock falls after Fuzzy Panda issues short report
Windsor Private Capital LP, along with other entities, disposed of 166,572 shares of Firefly Neurosciences Inc. (AIFF:AIFF) common stock between October 9 and October 14, 2025. The sales, conducted in accordance with Rule 144, resulted in proceeds totaling $456677. The prices obtained for these shares ranged from $2.6525 to $2.9441. The transaction comes amid a challenging week for Firefly, with the stock declining nearly 8% over the past week. According to InvestingPro data, the company maintains strong liquidity with a current ratio of 2.69 and impressive gross margins of 94%.
The shares were indirectly held by Windsor Private Capital LP. Following these transactions, Windsor Private Capital LP still indirectly owns 1470201 shares of Firefly Neurosciences Inc., representing a significant stake in the $37.12M market cap company. InvestingPro analysis suggests the stock is slightly overvalued at current levels, with additional insights available through their premium service.
In other recent news, Firefly Neuroscience Inc. announced a collaboration with Heidelberg University Hospital to conduct a study on the neurophysiological effects of 15q13.3 copy number variants (CNVs). This research, led by Prof. Dr. med. Christian Schaaf, aims to analyze electroencephalogram (EEG) data from 30 subjects using Firefly’s FDA-cleared technology. The study will focus on identifying electrophysiological biomarkers and characterizing neurocognitive profiles linked to deletions versus duplications in the 15q13.3 chromosomal region. Scheduled to run through 2026, the study employs Firefly’s Brain Network Analytics technology to process resting state and cognitive paradigm data. These recent developments highlight Firefly’s ongoing efforts in the field of brain health outcomes.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.